Guanosine

Guanosine

SCHEMBL9238739

CP(=O)(O)O.Nc1nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NT5E P21589 1/20 0.69
HPGD P15428 1/20 0.68
TGM2 P21980 1/20 0.64
HINT1 P49773 3/20 0.64
FUT5 Q11128 1/20 0.59
PNP P00491 1/20 0.59
PAX8 Q06710 1/20 0.59
IMPDH2 P12268 1/20 0.58
IMPDH1 P20839 1/20 0.58
KRAS P01116 4/20 0.58
GSK3A P49840 2/20 0.58
RPS6KA3 P51812 2/20 0.58
MAPK14 Q16539 2/20 0.58
CYP2C19 P33261 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Guanosine SCHEMBL31361372 0.96 NT5E (0.72) NT5EHPGDTGM2HINT1FUT5
Guanosine SCHEMBL376138 0.96 NT5E (0.72) NT5EHPGDTGM2HINT1FUT5
Guanosine SCHEMBL1304255 0.96 NT5E (0.72) NT5EHPGDTGM2HINT1FUT5
Guanosine SCHEMBL44407 0.96 NT5E (0.72) NT5EHPGDTGM2HINT1FUT5
Guanosine SCHEMBL2589323 0.96 NT5E (0.72) NT5EHPGDTGM2HINT1FUT5
Guanosine SCHEMBL94793 0.96 NT5E (0.72) NT5EHPGDTGM2HINT1FUT5
Guanosine SCHEMBL8719176 0.95 NT5E (0.70) NT5EHPGDTGM2HINT1FUT5
Guanosine SCHEMBL5356557 0.95 NT5E (0.70) NT5EHPGDTGM2HINT1FUT5
Guanosine SCHEMBL1444901 0.94 NT5E (0.69) NT5EHPGDTGM2HINT1FUT5
Guanosine SCHEMBL21315718 0.94 HPGD (0.71) NT5EHPGDTGM2HINT1PNP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0653438-A2 Oligonucleotide compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-05-17 EP disclosed